Biological activity of an intravenous preparation of human vaccinia immune globulin in mouse models of vaccinia virus infection (Q33883711)

29 July 2017

Biological activity of an intravenous preparation of human vaccinia immune globulin in mouse models of vaccinia virus infection (English)

1 reference

29 July 2017

vaccinia virus

1 reference

Jeffry D Shearer

1

1 reference

29 July 2017

Linda Siemann

series ordinal

2

1 reference

29 July 2017

Mary Gerkovich

series ordinal

3

1 reference

29 July 2017

Robert V House

series ordinal

4

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 July 2005

1 reference

Antimicrobial Agents and Chemotherapy

29 July 2017

1 reference

29 July 2017

49

1 reference

29 July 2017

7

1 reference

29 July 2017

2634-2641

1 reference

Safety and pharmacokinetic evaluation of intravenous vaccinia immune globulin in healthy volunteers

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168682

Evaluating the validity of animal models for research into therapies for immune-based disorders

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168682

Intravenous immunoglobulin products contain neutralizing antibodies to vaccinia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168682

Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168682

Pathogenesis and potential antiviral therapy of complications of smallpox vaccination

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168682

Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168682

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168682

A review of compounds exhibiting anti-orthopoxvirus activity in animal models

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168682

Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168682

Effect of 5-iodo-2'-deoxyuridine on vaccinia virus (orthopoxvirus) infections in mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168682

Efficacy of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine for treatment of vaccinia virus (orthopoxvirus) infections in mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168682

Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for the treatment of lethal vaccinia virus infections in severe combined immune deficiency (SCID) mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168682

Effect of Interferon, Polyacrylic Acid, and Polymethacrylic Acid on Tail Lesions in Mice Infected with Vaccinia Virus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168682

Complications of smallpox vaccination, 1968: results of ten statewide surveys

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168682

Complications of smallpox vaccination United States 1963. II. Results obtained by four statewide surveys.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168682

Complications of smallpox vaccination. I. National survey in the United States, 1963.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168682

Experience of anti-vaccinia immunoglobulin in the United Kingdom.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168682

Effect of cytosine, arabinoside, iododeoxyuridine, ethyldeoxyuridine, thiocyanatodeoxyuridine, and ribavirin on tail lesion formation in mice infected with vaccinia virus

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168682

Smallpox vaccination reactions, prophylaxis, and therapy of complications

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168682

Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaques

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1168682

Update: cardiac and other adverse events following civilian smallpox vaccination--United States, 2003

29 October 2018

1 reference

12 December 2020

Evaluation of antiviral compounds by suppression of tail lesions in vaccinia-infected mice

1 reference

12 December 2020

Deaths attributable to smallpox vaccination, 1959 to 1966, and 1968

1 reference

12 December 2020

Hyperimmune vaccinal gamma globulin; source, evaluation, and use in prophylaxis and therapy

1 reference

12 December 2020

10.1128/AAC.49.7.2634-2641.2005

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference